Effector pathways regulating T cell activation

Biochemical Pharmacology

Volumn 56, Issue 12, 1998, Pages 1539-1547

  Favero, Jean ^a   Lafont, Virginie ^a  

^a INSERM   (France)

Author keywords

CD28 signaling; Interleukin 2; Mitogen activated (MAP) kinases; Protein tyrosine kinase; T lymphocyte activation; TcR signaling

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CD3 ANTIGEN; INTERLEUKIN 2; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN TYROSINE KINASE; T LYMPHOCYTE RECEPTOR; TACROLIMUS;

ANTIGEN PRESENTING CELL; IMMUNE RESPONSE; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

EID: 0031743998     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(98)00213-5     Document Type: Article

References (137)

1. Baniyash M, Garcia-Morales P, Luong E, Samelson LE and Klausner RD, The T cell antigen receptor ζ chain is tyrosine phosphorylated upon activation. J Biol Chem 263: 18225-18230, 1988.
2. Reth M, Antigen receptor tail clue. Nature 338: 383-384, 1989.
3. Qian D, Griswold-Prenner I, Rosner MR and Fitch FW, Multiple components of the T cell antigen receptor complex become tyrosine-phosphorylated upon activation. J Biol Chem 268: 4488-4493, 1993.
4. Osman N, Lucas S and Cantrell D, The role of tyrosine phosphorylation in the interaction of cellular tyrosine kinases with the T cell receptor ζ chain tyrosine-based activation motif. Eur J Immunol 25: 2863-2869, 1995.
5. Osman N, Turner H, Lucas S, Reif K and Cantrell DA, The protein interactions of the immunoglobulin receptor family tyrosine-based activation motifs present in the T cell receptor ζ subunits and the CD3 γ, δ and ε chains. Eur J Immunol 26: 1063-1068, 1996.
6. Straus DB and Weiss A, Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor. Cell 70: 585-593, 1992.
7. lck deficiency on the growth and cytolytic effector function of an interleukin-2-dependent cytotoxic T-cell line. Mol Cell Biol 12: 4521-4530, 1992.
8. Iwashima M, Irving BA, van Oers NSC, Chan AC and Weiss A, Sequential interactions of the TCR with two distinct cytoplasmic tyrosine kinases. Science 263: 1136-1139, 1994.
9. Hall CG, Sancho J and Terhorst C, Reconstitution of T cell receptor ζ-mediated calcium mobilization in nonlymphoid cells. Science 261: 915-918, 1993.
10. van Oers NSC, Killeen N and Weiss A, Lck regulates the tyrosine phosphorylation of the T cell receptor subunits and ZAP-70 in murine thymocytes. J Exp Med 183: 1053-1062, 1996.
11. Chan AC, Iwashima M, Turck CW and Weiss A, ZAP-70: A 70 kd protein-tyrosine kinase that associates with the TCR ζ chain. Cell 71: 649-662, 1992.
12. Wange RL, Malek SN, Desiderio S and Samelson LE, Tandem SH2 domains of ZAP-70 bind to T cell antigen receptor ζ and CD3ε from activated Jurkat T cells. J Biol Chem 268: 19797-19801, 1993.
13. Koyasu S, Tse AGD, Moingeon P, Hussey RE, Mildonian A, Hannisian J, Clayton LK and Reinherz EL, Delineation of a T cell activation motif required for binding of protein tyrosine kinases containing tandem SH2 domains. Proc Natl Acad Sci USA 91: 6693-6697, 1994.
14. Burkhardt AL, Stealey B, Rowley RB, Mahajan S, Prendergast M, Fargnoli J and Bolen RB, Temporal regulation of non-transmembrane protein kinase enzyme activity following T cell antigen receptor engagement. J Biol Chem 269: 23642-23647, 1994.
15. Wange RL, Guitian R, Isakov N, Watts JD, Aebersold R and Samelson LE, Activating and inhibitory mutations in adjacent tyrosines in the kinase domain of ZAP-70. J Biol Chem 270: 18730-18733, 1995.
16. Chan AC, Dalton M, Johnson R, Kong GH, Wang T, Thoma R and Kurosaki T, Activation of ZAP-70 kinase activity by phosphorylation of tyrosine 493 is required for lymphocyte antigen receptor function. EMBO J 14: 2499-2508, 1995.
17. Schreiber SL and Crabtree GR, The mechanism of action of cyclosporin A and FK 506. Immunol Today 13: 136-142, 1992.
18. Rao A, NF-ATp: A transcription factor required for the co-ordinate induction of several cytokine genes. Immunol Today 15: 274-281, 1994.
19. Jain J, Loh C and Rao A, Transcriptional regulation of the IL-2 gene. Curr Opin Immunol 7: 333-342, 1995.
20. Brabletz T, Pietrowski I and Serfling E, The immunosuppressives FK 506 and cyclosporin A inhibit the generation of protein factors binding to the two purine boxes of the interleukin 2 enhancer. Nucleic Acids Res 19: 61-67, 1991.
21. Thompson CB, Wang C-Y, Ho I-C, Bohjanen PR, Petryniak B, June CH, Miesfeldt S, Zhang L, Nabel GJ, Karpinski B and Leiden JM, cis-Acting sequences required for inducible interleukin-2 enhancer function bind a novel Ets-related protein, Elf-1. Mol Cell Biol 12: 1043-1053, 1992.
22. Weiss A and Littman DR, Signal transduction by lymphocyte antigen receptors. Cell 76: 263-274, 1994.
23. Imboden JB and Stobo JD, Transmembrane signaling by the T cell antigen receptor: Perturbation of the T3 antigen receptor complex generates inositol phosphates and releases calcium ions from intracellular stores. J Exp Med 161: 446-456, 1985.
24. Secrist JP, Karnitz L and Abraham RT, T-cell antigen receptor ligation induces tyrosine phosphorylation of phospholipase C-γ1. J Biol Chem 266: 12135-12139, 1991.
25. Weiss A, Koretzky G, Schatzman R and Kadlecek T, Stimulation of the T cell antigen receptor induces tyrosine phosphorylation of phospholipase C-γ1. Proc Natl Acad Sci USA 88: 5484-5488, 1991.
26. Graber M, June CH, Samelson LE and Weiss A, The protein tyrosine kinase inhibitor herbimycin A, but not genistein, specifically inhibits signal transduction by the T cell antigen receptor. Int Immunol 4: 1201-1210, 1992.
27. June CH, Fletcher MC, Ledbetter JA, Schieven GL, Siegel JN, Philips AF and Samelson LE, Inhibition of tyrosine phosphorylation prevents T cell receptor-mediated signal transduction. Proc Natl Acad Sci USA 87: 7722-7726, 1990.
28. Dasgupta JD, Granja C, Druker B, Lin L-L, Yunis EJ and Relias V, Phospholipase C-γ1 association with CD3 structure in T cells. J Exp Med 175: 285-288, 1992.
29. Weber JR, Bell GM, Han MY, Pawson T and Imboden JB, Association of the tyrosine kinase LCK with phospholipase C-γ1 after stimulation of the T cell antigen receptor. J Exp Med 176: 373-379, 1992.
30. Crabtree GR and Clipstone NA, Signal transmission between the plasma membrane and nucleus of T-lymphocytes. Annu Rev Biochem 63: 1045-1083, 1994.
31. Tocci MJ, Matkovitch DA, Collier KA, Kwok P, Dumont F, Lin S, Degudicibus S, Siekierka JJ, Chin J and Huchinson NI, The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes. J Immunol 143: 718-726, 1989.
32. Shaw J, Meerovitch K, Elliott JF, Bleackley RC and Paetkau V, Induction, suppression and superinduction of lymphokine mRNA in T-lymphocytes. Mol Immunol 24: 409-419, 1987.
33. Liu J, FK506 and cyclosporin: Molecular probes for studying intracellular signal transduction. Immunol Today 14: 290-295, 1993.
34. Bierer BE, Hollander G, Fruman D and Burakoff SJ, Cyclosporin A and FK506: Molecular mechanism of immunosuppression and probes for transplantation biology. Curr Opin Immunol 5: 763-773, 1993.
35. Bram RJ, Hung DT, Martin PK, Schreiber SL and Crabtree GR, Identification of the immunophilins capable of mediating inhibition of signal transduction by cyclosporin A and FK506: Roles of calcineurin binding and cellular location. Mol Cell Biol 13: 4760-4769, 1993.
36. Milan D, Griffith J, Su M, Price ER and McKeon F, The latch region of calcineurin B is involved in both immunosuppressant-immunophilin complex docking and phosphatase activation. Cell 79: 437-447, 1994.
37. ras in T cells. Immunol Today 13: 89-92, 1992.
38. ras during T-cell activation and growth. Immunol Today 16: 159-164, 1995.
39. Cantrell D, G proteins in lymphocyte signalling. Curr Opin Immunol 6: 380-384, 1994.
40. Genot EM, Parker PJ and Cantrell DA, Analysis of the role of protein kinase C-α, -ε, and -ζ in T cell activation. J Biol Chem 270: 9833-9839, 1995.
41. Nel AE, Hanekom C and Hultin L, Protein kinase C plays a role in the induction of tyrosine phosphorylation of lymphoid microtubule-associated protein-2 kinase. J Immunol 147: 1933-1939, 1991.
42. Izquierdo M, Leevers SJ, Williams DH, Marshall CJ, Weiss A and Cantrell D, The role of protein kinase C in the regulation of extracellular signal-regulated kinase by the T cell antigen receptor. Eur J Immunol 24: 2462-2468, 1994.
43. ras in activated T cells. Eur J Immunol 25: 42-47, 1995.
44. Foletta VC, Segal DH and Cohen DR, Transcriptional regulation in the immune system: All roads lead to AP-1. J Leukoc Biol 63: 139-152, 1998.
45. Jain J, Valge-Archer VE and Rao A, Analysis of the AP-1 sites in the IL-2 promoter. J Immunol 148: 1240-1250, 1992.
46. p is a substrate for calcineurin and interacts with Fos and Jun. Nature 365: 352-355, 1993.
47. Jain J, McCaffrey PG, Valge-Archer VE and Rao A, Nuclear factor of activated T-cells contains Fos and Jun. Nature 356: 801-804, 1992.
48. Marais R, Wynne J and Treisman R, The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain. Cell 73: 381-393, 1993.
49. Whitmarsh AJ, Shore P, Sharrocks AD and Davis RJ, Integration of MAP kinase signal transduction pathways at the serum response element. Science 269: 403-407, 1995.
50. Cavigelli M, Dolfi F, Claret F-X and Karin M, Induction of c-fos expression through JNK-mediated TCF/Elk-1 phosphorylation. EMBO J 14: 5957-5964, 1995.
51. Price MA, Cruzalegui FH and Treisman R, The p38 and ERK MAP kinase pathways cooperate to activate ternary complex factors and c-fos transcription in response to UV light. EMBO J 15: 6552-6563, 1996.
52. Dérijard B, Hibi M, Wu I-H, Barrett T, Su B, Deng T, Karin M and Davis RJ, JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76: 1025-1037, 1994.
53. Su B and Karin M, Mitogen-activated protein kinase cascades and regulation of gene expression. Curr Opin Immunol 8: 402-411, 1996.
54. Baldari CT, Macchia G and Telford JL, Interleukin-2 promoter activation in T-cells expressing activated Ha-ras. J Biol Chem 267: 4289-4291, 1992.
55. ras mediates control of IL-2 gene promoter function in T cell activation. EMBO J 11: 4549-4556, 1992.
56. ras and Calcineurin synergize to regulate the nuclear factor of activated T cells. J Exp Med 178: 1517-1522, 1993.
57. ras Function is important for T cell antigen receptor and protein kinase C regulation of nuclear factor of activated T cells. J Immunol 150: 3853-3861, 1993.
58. Fraser JD, Straus D and Weiss A, Signal transduction events leading to T-cell lymphokine gene expression. Immunol Today 14: 357-362, 1993.
59. ras couples the T cell antigen receptor to extracellular signalregulated kinase 2 in T lymphocytes. J Exp Med 178: 1199-1208, 1993.
60. Marshall CJ, MAP kinase kinase kinase, MAP kinase kinase and MAP kinase. Curr Opin Genet Dev 4: 82-89, 1994.
61. Cobb M and Goldsmith E, How MAP kinases are regulated. J Biol Chem 270: 14843-14846, 1995.
62. Jelinek T, Catling AD, Reuter CWM, Moodie SA, Wolfman A and Weber MJ, RAS and RAF-1 form a signalling complex with MEK-1 but not MEK-2. Mol Cell Biol 14: 8212-8218, 1994.
63. Howe LR, Leevers SJ, Gómez N, Nakielny S, Cohen P and Marshall CJ, Activation of the MAP kinase pathway by the protein kinase raf. Cell 71: 335-342, 1992.
64. Warne PH, Rodriguez Viciana P and Downward J, Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro. Nature 364: 352-355, 1993.
65. Izquierdo M, Bowden S and Cantrell D, The role of Raf-1 in the regulation of extracellular signal-regulated kinase 2 by the T cell antigen receptor. J Exp Med 180: 401-406, 1994.
66. Leevers SJ, Paterson HF and Marshall CJ, Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane. Nature 369: 411-414, 1994.
67. Owaki H, Varma R, Gillis B, Bruder JT, Rapp UR, Davis LS and Geppert TD, Raf-1 is required for T cell IL2 production. EMBO J 12: 4367-4373, 1993.
68. Whitehurst CE and Geppert TD, MEK1 and the extracellular signal-regulated kinases are required for the stimulation of IL-2 gene transcription in T cells. J Immunol 156: 1020-1029, 1996.
69. Alberola-Ila J, Forbush KA, Seger R, Krebs EG and Perlmutter RM, Selective requirement for MAP kinase activation in thymocyte differentiation. Nature 273: 620-623, 1995.
70. Genot E, Cleverley S, Henning S and Cantrell D, Multiple p21ras effector pathways regulate nuclear factor of activated T cells. EMBO J 15: 3923-3933, 1996.
71. Hall A, Small GTP-binding proteins and the regulation of the actin cytoskeleton. Annu Rev Cell Biol 10: 31-54, 1994.
72. Qiu R-G, Chen J, Kim D, McCormick F and Symons M, An essential role for Rac in Ras transformation. Nature 374: 457-459, 1995.
73. Coso OA, Chiariello M, Yu J-C, Teramoto H, Crespo P, Xu N, Miki T and Gutkind JS, The small GTP-binding proteins Rac-1 and Cdc 42 regulate the activity of the JNK/SAPK signaling pathway. Cell 81: 1137-1146, 1995.
74. Minden A, Lin A, Claret FX, Abo A and Karin M, Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell 81: 1147-1157, 1995.
75. Jacinto E, Werlen G and Karin M, Cooperation between Syk and Rac1 leads to synergistic JNK activation in T lymphocytes. Immunity 8: 31-41, 1998.
76. Turner H and Cantrell DA, Distinct Ras effector pathways are involved in FrεR1 regulation of the transcriptional activity of Elk-1 and NFAT in mast cells. J Exp Med 185: 43-53, 1997.
77. Ballester A, Tobena R, Lisbona C, Calvo V and Alemany S, Cot kinase regulation of IL-2 production in Jurkat T cells. J Immunol 159: 1613-1618, 1997.
78. Lafont V, Rouot B and Favero J, The Raf-1/mitogen-activated protein kinase kinase-1/extracellular signal-regulated-2 signaling pathway as prerequisite for interleukin-2 gene transcription in lectin-stimulated human primary T lymphocytes. Biochem Pharmacol 55: 319-324, 1998.
79. Dudley DT, Pang L, Decker SJ, Bridges AJ and Saltiel AR, A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci USA 92: 7686-7689, 1995.
80. ras and Raf-1 responses but not the Erk-1 response to granulocyte-colony-stimulating factor: Possible Raf-1-independent activation of Erk-1. Biochem J 322: 79-87, 1997.
81. Egerton M, Fitzpatrick DR, Catling AD and Kelso A, Differential activation of T cell cytokine production by the extracellular signal-regulated kinase (ERK) signaling pathway. Eur J Immunol 26: 2279-2285, 1996.
82. June CH, Bluestone JA, Nadler LM and Thompson CB, The B7 and CD28 receptor families. Immunol Today 15: 321-331, 1995.
83. Lenschow DJ, Walunas TL and Bluestone JA, CD28/B7 system of T cell costimulation. Immunol Rev 14: 233-258, 1996.
84. Jenkins MK, The ups and downs of T cell costimulation. Immunity 1: 443-446, 1994.
85. Harding FA, McArthur JG, Gross JA, Raulet DH and Allison JP, CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 356: 607-609, 1992.
86. Boussiotis VA, Freeman GJ, Gray GS, Gribben JG and Nadler LM, B7 but not intercellular adhesion molecule-1 costimulation prevents the induction of human alloantigen-specific tolerance. J Exp Med 178: 1753-1763, 1993.
87. Gimmi CD, Freeman GJ, Gribben JG, Gray G and Nadler LM, Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation. Proc Natl Acad Sci USA 90: 6586-6590, 1993.
88. Tan P, Anasetti C, Hansen JA, Melrose J, Brunvand M, Bradshaw J, Ledbetter JA and Linsley PS, Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1. J Exp Med 177: 165-173, 1993.
89. L. Immunity 3: 87-98, 1995.
90. Colette Y, Razanajaona D, Ghiotto M and Olive D, CD28 can promote T cell survival through a phosphatidylinositol 3-kinase-independent mechanism. Eur J Immunol 27: 3283-3289, 1997.
91. Ward SG, CD28: A signalling perspective. Biochem J 318: 361-377, 1996.
92. Rudd CE, Upstream-downstream: CD28 cosignaling pathways and T cell function. Immunity 4: 527-534, 1996.
93. Thompson CB and Allison JP, The emerging role of CTLA-4 as an immune attenuator. Immunity 7: 445-450, 1997.
94. Linsley PS, Distinct roles for CD28 and cytotoxic T lymphocyte-associated molecule-4 receptors during T cell activation? J Exp Med 182: 289-292, 1995.
95. Sperling AI, Auger JA, Ehst BD, Rulifson IC, Thompson CB and Bluestone JA, CD28/B7 interactions deliver a unique signal to naive T cells that regulates cell survival but not early proliferation. J Immunol 157: 3909-3917, 1996.
96. Take M, Hanke G, Hanke T and Hunig T, CD28-mediated induction of proliferation in resting T cells in vitro and in vivo without engagement of the T cell receptor: Evidence for functionally distinct forms of CD28. Eur J Immunol 27: 239-247, 1997.
97. Ledbetter JA and Linsley PS, CD28 receptor crosslinking induces tyrosine phosphorylation of PLCγl. Adv Exp Med Biol 323: 23-27, 1992.
98. Pages F, Ragueneau M, Rottapel R, Truneh A, Nunes J, Imbert J and Olive D, Binding of phosphatidylinositol-3-OH kinase to CD28 is required for T-cell signalling. Nature 369: 327-329, 1994.
99. Fyn regulate CD28 binding to phosphatidylinositol 3-kinase, growth factor receptor-bound protein GRB-2, and T cell-specific protein-tyrosine kinase ITK: Implications for T-cell costimulation. Proc Natl Acad Sci USA 92: 8891-8895, 1995.
100. Koretzky GA, The role of Grb2-associated proteins in T cell activation. Immunol Today 18: 401-406, 1997.
101. ras. Eur J Immunol 25: 1044-1050, 1995.
102. ras. J Exp Med 180: 1067-1076, 1994.
103. Ward SG, June CH and Olive D, P13-kinase: A pivotal pathway in T cell activation? Immunol Today 17: 187-197, 1996.
104. Stephens LR, Jackson TR and Hawkins PT, Agonist-stimulated synthesis of phosphatidylinositol(3,4,5)-trisphosphate: A new intracellular signalling system? Biochim Biophys Acta 1179: 27-75, 1993.
105. 3. J Biol Chem 269: 32358-32367, 1994.
106. Nakanishi H, Brewer KA and Exton JH, Activation of the ζ isozyme of protein kinase C by phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 268: 13-16, 1993.
107. Franke TF, Yang S-I, Chan TO, Datta K, Kazlauskas A, Morrison DK, Kaplan DR and Tsichlis PN, The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 81: 727-736, 1995.
108. Hu Q, Klippel A, Muslin AJ, Fanti WJ and Williams LT, Ras dependent induction of cellular responses by constitutively active phosphatidylinositol 3-kinase. Science 268: 100-102, 1995.
109. Rodriguez-Viciana P, Warne PH, Dhand R, Vanhaesebroeck B, Gout I, Fry MJ, Waterfield MD and Downward J, Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature 370: 527-532, 1994.
110. Yano H, Nakanishi S, Kimura K, Hanai N, Saitoh Y, Fukui Y, Nonomura Y and Matsuda Y, Inhibition of histamine secretion by wortmannin through the blockade of phosphatidylinositol 3-kinase in RBL-2H3 cells. J Biol Chem 268: 25846-25856, 1993.
111. Ueda Y, Levine B, Freeman GJ, Nadler LM, June CH and Ward SG, Both CD28 ligands CD80 (B7-1) and CD86 (B7-2) activate phosphatidylinositol 3-kinase, and wortmannin reveals heterogeneity in the regulation of T cell IL-2 secretion. Int Immunol 7: 957-966, 1995.
112. Lu Y, Phillips CA and Trevillyan JM, Phosphatidylinositol 3-kinase activity is not essential for CD28 costimulatory activity in Jurkat T cells: Studies with a selective inhibitor, wortmannin. Eur J Immunol 25: 533-537, 1995.
113. Hutchcroft JE, Frankin DP, Tsai B, Harrison-Findik D, Vaticovski L and Bierer BE, Phorbol ester treatment inhibits phosphatidylinositol 3-kinase activation by, and association with CD28, a T-lymphocyte surface receptor. Proc Natl Acad Sci USA 92: 8808-8812, 1995.
114. Truitt KE, Shi J, Gibson S, Segal LG, Mills GB and Imboden JB, CD28 delivers costimulatory signals independently of its association with phosphatidylinositol 3-kinase. J Immunol 155: 4702-4710, 1995.
115. Ward SG, Wilson A, Turner L, Westwick J and Sansom DM, Inhibition of CD28-mediated T cell costimulation by the phosphoinositide 3-kinase inhibitor wortmannin. Eur J Immunol 25: 526-532, 1995.
116. Ghiotto-Ragueneau M, Battifora M, Truneh A, Waterfield MD and Olive D, Comparison of CD28-B7.1 and B7.2 functional interaction in resting human T cells: Phosphatidylinositol 3-kinase association to CD28 and cytokine production. Eur J Immunol 26: 34-41, 1996.
117. August A, Gibson S, Kawakami Y, Kawakami T, Mills GB and Dupont B, CD28 is associated with and induces the immediate tyrosine phosphorylation and activation of the Tec family kinase ITK/EMT in the human Jurkat leukemic T cell line. Proc Natl Acad Sci USA 91: 9347-9351, 1994.
118. Heyeck SD and Berg LJ, Developmental regulation of a murine T-cell-specific tyrosine kinase gene, Tsk. Proc Natl Acad Sci USA 90: 669-673, 1993.
119. Siciliano JD, Morrow TA and Desiderio SV, itk, a T-cell-specific tyrosine kinase gene inducible by interleukin 2. Proc Natl Acad Sei USA 89: 11194-11198, 1992.
120. Yamada N, Kawakami Y, Kimura H, Fukamachi H, Baier G, Altman A, Kato T, Inagaki Y and Kawakami T, Structure and expression of novel protein-tyrosine kinases, Emb and Emt, in hematopoietic cells. Biochem Biophys Res Commun 192: 231-240, 1993.
121. Gibson S, Leung B, Squire JA, Hill M, Arima N, Goss P, Hogg D and Mills GB, Identification, cloning, and characterization of a novel human T-cell-specific tyrosine kinase located at the hematopoietin complex on chromosome 5q. Blood 82: 1561-1572, 1993.
122. Liao XC and Littman DR, Altered T cell receptor signaling and disrupted T cell development in mice lacking Itk. Immunity 3: 757-769, 1995.
123. Gibson S, August A, Branch D, Dupont B and Mills GB, Functional LCK is required for optimal CD28-mediated activation of the TEC family tyrosine kinase EMT/ITK. J Biol Chem 271: 7079-7083, 1996.
124. King PD, Sadra A, Teng JMC, Liu X-R, Han A, Selvakumar A, August A and Dupont B, Analysis of CD28 cytoplasmic tail residues as regulators and substrates for the protein tyrosine kinases, EMT and Lck. J Immunol 158: 580-590, 1997.
125. Liao XC, Fournier S, Killeen N, Weiss A, Allison JP and Littman DR, Itk negatively regulates induction of T cell proliferation by CD28 costimulation. J Exp Med 186: 221-228, 1997.
126. Boucher LM, Wiegmann K, Futterer A, Pfeffer K, Machleidt T, Schutze S, Mak TW and Kronke M, CD28 signals through acidic sphingomyelinase. J Exp Med 181: 2059-2068, 1995.
127. Chan G and Ochi A, Sphingomyelin-ceramide turnover in CD28 costimulatory signaling. Eur J Immunol 25: 1999-2004, 1995.
128. Yao B, Zhang Y, Delikat S, Mathias S, Basu S and Kolesnick R, Phosphorylation of Raf by ceramide-activated protein kinase. Nature 378: 307-310, 1995.
129. Westwick JK, Bielawska AE, Dbaibo G, Hannun YA and Brenner DA, Ceramide activates the stress-activated protein kinases. J Biol Chem 270: 22689-22692, 1995.
130. Lozano J, Berra E, Municio MM, Diaz-Meco MT, Dominguez I, Sanz L and Moscat J, Protein kinase C ζ isoform is critical for κB-dependent promoter activation by sphingomyelinase. J Biol Chem 269: 19200-19202, 1994.
131. Muller G, Ayoub M, Storz P, Rennecke J, Fabbro D and Pfizenmaier K, PKCζ is a molecular switch in signal transduction of TNFα bifunctionally regulated by ceramide and arachidonic acid. EMBO J 14: 1961-1969, 1995.
132. Kolesnick R, Spingomyelin and derivatives as cellular signals. Prog Lipid Res 30: 1-38, 1991.
133. Wiegmann K, Schutze S, Machleidt T, Witte D and Kronke M, Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell 78: 1005-1015, 1994.
134. Edmead CE, Patel YI, Wilson A, Boulougouris G, Hall ND, Ward SG and Sansom DM, Induction of activator protein (AP)-1 and nuclear factor-κB by CD28 stimulation involves both phosphatidylinositol 3-kinase and acidic sphingomyelinase signals. J Immunol 157: 3290-3297, 1996.
135. Parker P, Intracellular signalling. PI 3-kinase puts GTP on the Rac. Curr Biol 5: 577-579, 1995.
136. Su B, Jacinto E, Hibi M, Kalluniki T, Karin M and Ben-Neriah Y, JNK is involved in signal integration during costimulation of T lymphocytes. Cell 77: 727-736, 1994.
137. Nunes J, Battifora JA, Woodgett JR, Truneh A, Olive D and Cantrell DA, CD28 signal transduction pathways. A comparison of B7-1 and B7-2 regulation of the map kinases: ERK2 and Jun kinases. Mol Immunol 33: 63-70, 1996.